Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Hexagem | 2022 | Grant | $2.3M | Lund |
| METAFORA biosystems | 2022 | Grant | $2.6M | Évry |
| Yabie | 2022 | Series Unknown | $16.0M | Stockholm |
| Cognibotics | 2022 | Series Unknown | $6.0M | Lund |
| CardiacSense | 2022 | Series A | $9.3M | Caesarea |
| Lyfta | 2022 | Series Unknown | $3.0M | Helsinki |
| NEC OncoImmunity AS | 2022 | Seed | $4.8M | Oslo |
| Deneb Medical | 2022 | Undisclosed | $272K | San Sebastian |
| CH-Bioforce Oy | 2022 | Grant | $16.5M | Espoo |
| New Born Solutions | 2022 | Grant | $2.8M | Barcelona |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 326 | Hexagem | Grant | $2.3M | Lund, Sweden |
| 327 | METAFORA biosystems | Grant | $2.6M | Évry, France |
| 328 | Yabie | Series Unknown | $16.0M | Stockholm, Sweden |
| 329 | Cognibotics | Series Unknown | $6.0M | Lund, Sweden |
| 330 | CardiacSense | Series A | $9.3M | Caesarea, Israel |
| 331 | Lyfta | Series Unknown | $3.0M | Helsinki, Finland |
| 332 | NEC OncoImmunity AS | Seed | $4.8M | Oslo, Norway |
| 333 | Deneb Medical | Undisclosed | $272K | San Sebastian, Spain |
| 334 | CH-Bioforce Oy | Grant | $16.5M | Espoo, Finland |
| 335 | New Born Solutions | Grant | $2.8M | Barcelona, Spain |
Hexagem develops dislocation-free GaN substrates for Power Electronics and relaxed InGaN platelets for µLED Displays
METAFORA biosystems is a biotechnology company developing the use of RBDs, innovative and unmatched ligands of nutrient transporters.
Yabie - One stop shop for in-store transactions and check-out. Fastest growing POS & Payment actor in Northern Europe
Cognibotics specializes in methods and services for high-performing and cost-effective determination of robot properties such as backlash.
CardiacSense is a developer of a wearable technology for continuous cardiac arrhythmia detection and non-inflating blood pressure monitoring
Lyfta is a platform where teachers can find beautiful, engaging, and immersive content to capture the hearts and minds of their students.
NEC OncoImmunity AS is an artificial intelligence driven biotech company.
Deneb Medical is a start-up dedicated to developing a robotic platform.
CH-Bioforce is the developer of the best biomass fractionation technology in the world.
New Born Solutions is a medical device company that provides non-invasive screening for infant meningitis.
K-Ryole is a privately held company that manufactures smart electric bike trailer.
Make smarter decisions for your paid campaigns with superhuman automated keyword management.
Denmark-based robotis company with a mission to bridge academic-based research to businesses. Focus is on commercializing robotics R&D.
Signia Therapeutics is an innovative French start-up company.
Mesensei is a mobile platform as a service (PaaS) for high-value communities and ecosystems.
MEDIKURA develops communication software for pharma companies
Optimiz enables remote containerised cargo inspections and claims optimisation
Prodsmart is real time process tracking for production lines and job shops. They turn any factory into a digital smart factory.
Depixus are pioneering the development of MAGNA, a novel genetic analysis technology for decoding the dynamic genome.
DHP Technology is a startup in the energy that aims to provide a contemporary energy supply that meets the requirements of the environment.
MaxWell Biosystems provides solutions to advance basic neuroscience research and accelerate preclinical drug discovery.
Ultraleap is working to create the most remarkable connection between people and technology.
Ncardia is an Operator of a biotechnology company intended to expedite drug discovery and development process.
Syrinjector LTD. is developing a full digital solution based on a novel portable automated syringe gun and software.
EISMEA has invested in 609 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
EISMEA's top investment sectors include Biotechnology, Health Care, Medical, Software, Artificial Intelligence (AI). The firm invests across 59 different industry categories.
Among tracked funding rounds, Ultraleap received $80.9M in a Series D round. EISMEA's total known invested capital is $1.0B.
EISMEA's average investment size is $4.1M across its portfolio of 609 companies.
Recent EISMEA portfolio additions include Hexagem, METAFORA biosystems, Yabie, Cognibotics, CardiacSense. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors